| Literature DB >> 24940478 |
Concetta Pirozzi1, Fabio G Numis1, Antonio Pagano1, Paolo Melillo2, Roberto Copetti3, Fernando Schiraldi1.
Abstract
BACKGROUND: Dyspnea is one of the most frequent complaints in the Emergency Department. Thoracic ultrasound should help to differentiate cardiogenic from non-cardiogenic causes of dyspnea. We evaluated whether the diagnostic accuracy can be improved by adding a point-of-care-ultrasonography (POC-US) to routine exams and if an early use of this technique produces any advantage.Entities:
Keywords: Diagnostic accuracy; Dyspnea; Emergency Department; Point-of-care-ultrasonography
Year: 2014 PMID: 24940478 PMCID: PMC4039047 DOI: 10.1186/2036-7902-6-5
Source DB: PubMed Journal: Crit Ultrasound J ISSN: 2036-3176
Figure 1Study design. ECG, electrocardiogram; CXR, chest radiograph; ABG, arterial blood gases.
Causes of dyspnea and their occurrence
| Acute heart failure (AHF) | 64/38 |
| Acute exacerbation of COPD (ECOPD)/asthma | 53/31.5 |
| Pneumonia | 51/30.3 |
| Acute respiratory distress syndrome (ARDS) | 14/8.3 |
| Massive pleural effusion | 7/4.1 |
| Acute pulmonary embolism | 9/5.3 |
Six possible causes of dyspnea and their diagnostic criteria
| AHF | Signs and symptoms of heart failure preserved or reduced systolic function of the left ventricle, CXR congestion |
| Acute exacerbation of COPD and asthma | History of COPD or asthma, typical findings at lung examination, airflow limitation, not fully reversible in COPD, fully reversible in asthma |
| Pneumonia | Fever, cough, leukocytosis, rales or abolished vesicular murmur, pulmonary infiltrate at CXR, positive cultures (eventually) |
| ARDS | Acute presentation within 1 week of a known clinical insult or new/worsening respiratory symptoms; chest imaging with bilateral opacities-not fully explained by effusions, lobar/lung collapse, or nodules; respiratory failure not fully explained by cardiac failure or fluid overload; PiO2/FiO2 < 200 |
| Massive pleural effusion | Vesicular murmur abolished at lung auscultation and dullness at percussion, massive pleural effusion at CXR or US |
| Acute pulmonary embolism | Signs and symptoms, prediction rules indicating high probability; multidetector computed tomography positive for pulmonary embolism; dilated, hypokinetic right ventricle with pressure overload signs (when the embolism determines a significatively hemodynamic impairment) |
POC-US patterns and the corresponding combination of ultrasonography findings
| AHF | Interstitial lung syndrome (the presence of multiple diffuse bilateral B-lines indicates interstitial syndrome) with reduced EF of the left ventricle or preserved EF with diastolic dysfunction |
| Pneumonia | Subpleural echo-poor region or one with tissue-like echo texture, with additional signs such as air/fluid bronchograms and adjacent B-lines (focal interstitial syndrome) |
| ARDS | Interstitial lung syndrome (the presence of multiple diffuse bilateral B-lines indicates interstitial syndrome), with non-homogeneous distribution of B-lines and spared areas, and normal systolic and diastolic function of the left ventricle |
| Massive pleural effusion | Anechoic space between parietal and visceral pleural and respiratory movement of the lung within the effusion |
| Possible pulmonary embolism | Dilated, hypokinetic RV with systolic septal dyskinesia plus dilated IVC with low collapsibility index (only found in massive or sub-massive pulmonary embolism) and eventually positive CUS of the groin or calf veins |
Patients’ characteristics
| Age (years) | 74.3 ± 11.4 | 74.5 ± 12.7 | 0.9 |
| BMI (kg/m2) | 28.5 ± 3 | 29 ± 3.4 | 0.3 |
| Heart rate (bpm) | 96.6 ± 20.8 | 110.6 ± 24 | <0.05 |
| Respiratory rate (bpm) | 28.5 ± 5.8 | 30.4 ± 5 | <0.05 |
| SBP (mmHg) | 148 ± 33 | 155 ± 37 | 0.19 |
| DBP (mmHg) | 85.6 ± 17.4 | 88 ± 18 | 0.38 |
| pH | 7.38 ± 0.1 | 7.37 ± 0.16 | 0.7 |
| pCO2 (mmHg) | 48.5 ± 17.5 | 44.1 ± 15.8 | 0.09 |
| pO2 (mmHg) | 63.8 ± 20.5 | 63.8 ± 28 | 1 |
| FiO2 (%) | 27.3 ± 11.6 | 25.6 ± 11.9 | 0.18 |
| SpO2 (%) | 87.3 ± 9.8 | 88 ± 8.4 | 0.6 |
| PaO2/FiO2 | 255 ± 89 | 260 ± 87 | 0.7 |
| HCO3- (mmol/L) | 27.4 ± 6.8 | 26 ± 6.2 | 0.16 |
| Lactate (mmol/L) | 2.03 ± 2.2 | 2.4 ± 1.9 | 0.24 |
| Troponin-T (ng/mL) | 0.15 ± 0.64 | 0.08 ± 0.15 | 0.34 |
| CRP (mg/dL) | 4.3 ± 7.3 | 6.8 ± 9.1 | 0.05 |
| WBC (×103/mL) | 9.7 ± 4.8 | 10.6 ± 12 | 0.5 |
| D-dimers (ng/dL) | 1,175.3 ± 1,351 | 1,991 ± 1,039 | 0.9 |
| COPD (%) | 59 | 46 | 0.48 |
| Renal failure (%) | 23.8 | 22.5 | 0.83 |
| Ischemic heart disease (%) | 50 | 36 | 0.07 |
| Heart failure (%) | 22,7 | 20 | 0.76 |
| Cerebral vasculopathy (%) | 30 | 32.5 | 0.56 |
| Diabetes (%) | 25 | 27.5 | 0.7 |
| Atrial fibrillation (%) | 18 | 20 | 0.76 |
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; CRP, C-reactive protein; WBC, white blood cell; COPD, chronic obstructive pulmonary disease.
Sensitivity and specificity of POC-US and standard protocol in diagnosis of acute dyspnea
| | ||||||
|---|---|---|---|---|---|---|
| AHF | 100 | 99 | 78.2 | 67.7 | 100 | 98.4 |
| ECOPD/asthma | 93 | 99 | 55.5 | 90.9 | 94.4 | 100 |
| Pneumonia | 92 | 98 | 14.2 | 97.1 | 93.3 | 98.5 |
| ARDS | 100 | 99 | 16.6 | 100 | 100 | 100 |
| Massive pleural effusion | 100 | 100 | 16.6 | 100 | 100 | 100 |
| Acute pulmonary embolism | 89 | 100 | 0 | 98.8 | 83.3 | 100 |
a The diagnosis after POC-US is the initial diagnosis for group 1 (G1) and the intermediate diagnosis for group 2 (G2), the diagnosis after standard protocol is the initial diagnosis for G2. AHF, acute heart failure; ECOPD, exacerbation of chronic obstructive pulmonary disease; ARDS, acute respiratory distress syndrome.